Genolution Balance Sheet Health
Financial Health criteria checks 4/6
Genolution has a total shareholder equity of ₩94.9B and total debt of ₩19.5B, which brings its debt-to-equity ratio to 20.5%. Its total assets and total liabilities are ₩116.1B and ₩21.2B respectively.
Key information
20.5%
Debt to equity ratio
₩19.50b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩43.27b |
| Equity | ₩94.90b |
| Total liabilities | ₩21.19b |
| Total assets | ₩116.09b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A225220's short term assets (₩49.7B) exceed its short term liabilities (₩6.0B).
Long Term Liabilities: A225220's short term assets (₩49.7B) exceed its long term liabilities (₩15.2B).
Debt to Equity History and Analysis
Debt Level: A225220 has more cash than its total debt.
Reducing Debt: A225220's debt to equity ratio has reduced from 73.4% to 20.5% over the past 5 years.
Debt Coverage: A225220's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A225220's interest payments on its debt are well covered by EBIT.